Generic Name and Formulations:
Brompheniramine maleate 2mg, pseudoephedrine HCl 30mg, dextromethorphan HBr 10mg; per 5mL; liq; contains alcohol 0.95% v/v; butterscotch flavor.
- ADA Releases Updated Guidelines for Managing Pediatric Type 1 Diabetes
- The Harmful Application of HIPAA: How to Protect Privacy and Patient Care
- Diabetes Risk Associated With Cirrhosis, Not Chronic HCV Infection, in HIV+ Patients
Indications for BROMFED-DM:
Cough and nasal congestion.
10mL every 4 hrs.
<2yrs: individualize. 2–6yrs: 2.5mL. 6–12yrs: 5mL. Both every 4 hrs. Max 6 doses/24 hours.
Asthma. Lower respiratory disorders. Neonates. Premature infants. Severe hypertension or cardiovascular disease. Within 14 days of MAOIs. Nursing mothers.
Diabetes. History of bronchial asthma. Glaucoma. GI or GU obstruction. Hypertension. Cardiovascular disease. Thyroid disease. Pregnancy (Cat.C).
Antihistamine + antitussive + sympathomimetic.
See Contraindications. Hypertensive crisis with MAOIs. Potentiates alcohol, other CNS depressants. β-blockers may increase pressor effects of sympathomimetics. Antagonizes antihypertensives.
Sedation, dizziness, anticholinergic effects, thickening of bronchial secretions; excitability in children.
Endocrinology Advisor Articles
- Cushing Syndrome Results in Poor Quality of Life Even After Remission
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Link Between Gestational Diabetes and Risk for CVD and Diabetes in Hispanic/Latina Population
- Clinical Characteristics Altering Risks and Benefits of Sulfonylureas and Thiazolidinedione Therapy in T2D
- 6 Factors Related to Inclusion in Health Care Workplace Identified
- Weight Gain After Quitting Smoking May Increase Risk for T2D